{
    "structure": {
        "primary_objectives": {
            "required": true,
            "components": [
                "Safety assessment",
                "Tolerability evaluation",
                "PK parameters (if applicable)"
            ]
        },
        "secondary_objectives": {
            "required": true,
            "components": [
                "PD markers",
                "Initial clinical activity",
                "Dose-response relationships"
            ]
        },
        "exploratory_objectives": {
            "required": false,
            "components": [
                "Biomarkers",
                "Mechanistic studies",
                "Population PK"
            ]
        }
    },
    "prompt_additions": [
        "Focus on safety and PK objectives",
        "Include clear measurable parameters",
        "Specify timing of assessments"
    ]
}
